Literature DB >> 15167152

Cost-effectiveness analysis and incremental cost-effectiveness ratios: uses and pitfalls.

Kiran Bambha1, W Ray Kim.   

Abstract

Cost-effectiveness analysis is a formal method of comparing alternative medical interventions with regard to their resource utilization (costs) and outcomes (effectiveness). The incremental cost-effectiveness ratio is an informative measure generated from such an analysis and represents the ratio of the difference in cost between two medical interventions to the difference in outcomes between the two interventions. Thus, the incremental cost-effectiveness ratio summarizes the additional cost per unit of health benefit gained in switching from one medical intervention to another. Although incremental cost-effectiveness ratios have limitations, when used in the proper context, these ratios serve as one of the important tools needed to help guide decisions about allocating scarce resources across competing medical programmes.

Mesh:

Year:  2004        PMID: 15167152     DOI: 10.1097/00042737-200406000-00003

Source DB:  PubMed          Journal:  Eur J Gastroenterol Hepatol        ISSN: 0954-691X            Impact factor:   2.566


  10 in total

1.  Prophylactic cholecystectomy in transplant patients: a decision analysis.

Authors:  Lillian S Kao; Christopher Flowers; David R Flum
Journal:  J Gastrointest Surg       Date:  2005 Sep-Oct       Impact factor: 3.452

Review 2.  Economic impact of minimally invasive lumbar surgery.

Authors:  Christoph P Hofstetter; Anna S Hofer; Michael Y Wang
Journal:  World J Orthop       Date:  2015-03-18

3.  The cost-effectiveness of surgical treatment of medial unicompartmental knee osteoarthritis in younger patients: a computer model-based evaluation.

Authors:  Joseph F Konopka; Andreas H Gomoll; Thomas S Thornhill; Jeffrey N Katz; Elena Losina
Journal:  J Bone Joint Surg Am       Date:  2015-05-20       Impact factor: 5.284

Review 4.  Cost-Effectiveness Analyses in Orthopaedic Surgery: Raising the Bar.

Authors:  Prashant V Rajan; Rameez A Qudsi; Lindsey L Wolf; Elena Losina
Journal:  J Bone Joint Surg Am       Date:  2017-07-05       Impact factor: 5.284

5.  Every child, every day, back to play: the PICUstars protocol - implementation of a nurse-led PICU liberation program.

Authors:  M Waak; J Harnischfeger; A Ferguson; K Gibbons; K H Nguyen; D Long
Journal:  BMC Pediatr       Date:  2022-05-13       Impact factor: 2.567

6.  Addition of adult-to-adult living donation to liver transplant programs improves survival but at an increased cost.

Authors:  Patrick G Northup; Michael M Abecassis; Michael J Englesbe; Jean C Emond; Vanessa D Lee; George J Stukenborg; Lan Tong; Carl L Berg
Journal:  Liver Transpl       Date:  2009-02       Impact factor: 5.799

7.  Cost-efficiency of myocardial contrast echocardiography in patients presenting to the emergency department with chest pain of suspected cardiac origin and a nondiagnostic electrocardiogram.

Authors:  Jared J Wyrick; Saul Kalvaitis; K John McConnell; Diana Rinkevich; Sanjiv Kaul; Kevin Wei
Journal:  Am J Cardiol       Date:  2008-07-09       Impact factor: 2.778

Review 8.  The Economic Costs of Autism Spectrum Disorder: A Literature Review.

Authors:  Nicky Rogge; Juliette Janssen
Journal:  J Autism Dev Disord       Date:  2019-07

9.  Evaluation of results and costs of high precision radiotherapy (VMAT) compared with conventional radiotherapy (3D) in the treatment of cancer patients with spinal cord compression of metastatic origin.

Authors:  Jon Cacicedo; Elisa Gómez Inhiesto; Maria Teresa Acaiturri Ayesta; Iker Ustarroz; Dirk Rades
Journal:  Rep Pract Oncol Radiother       Date:  2022-09-19

10.  Diagnostic Yield and Economic Implications of Whole-Exome Sequencing for ASD Diagnosis in Israel.

Authors:  Rotem Tal-Ben Ishay; Apurba Shil; Shirley Solomon; Noa Sadigurschi; Hadeel Abu-Kaf; Gal Meiri; Hagit Flusser; Analya Michaelovski; Ilan Dinstein; Hava Golan; Nadav Davidovitch; Idan Menashe
Journal:  Genes (Basel)       Date:  2021-12-23       Impact factor: 4.096

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.